Complete Your Training and CertificationDownload Forms
Download the Application and the CMA Test below. Complete both forms and return by mail or email.
For more information contact. Walter Ginter, CMA, Director of Training |
Complete Your Training and CertificationDownload Forms
Download the Application and the CMA Test below. Complete both forms and return by mail or email.
For more information contact. Walter Ginter, CMA, Director of Training |
FALSE! Current research shows that doses below 60 mg/day are “not effective and hence not appropriate” and that low dose policies for pregnant and non-pregnant patients are associated with increased drug use as well as reduced program retention. Medical withdrawal of opioid dependent women is not recommended in pregnancy because of increased risk to the…
Issues To Focus On Massachusetts Restores Methadone Funding Highlights from a compromise budget plan unveiled by House and Senate leaders on Thursday The $22.3 billion plan would: Restore Medicaid funding for 36,000 people under MassHealth Basic; Preserve a popular prescription drug coverage program for the elderly; Repeal the voter-approved Clean Elections law; Tighten the Quinn…
2004 2005 2006 2007 2009 2016
Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award! NAMA Recovery AATOD Lane Holden Award May 1, 2022 | 0 Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive…
Workshop Wednesday, October 10th Past Present and Future: A Selection of Unfinished Business in Methadone Treatment Moderator, Howard Lotsof, NAMA Acting Membership Director Gary Nessenbaum, Washington Advocates for Methadone Maintenance (President). The Patients’ Perspectives on the Changes in the Methadone Treatment System. Carmen Pearman, NAMA Regional Director and The MAG of Indiana (President). Tapering –…
From NIDDK Fact Sheet Chronic Hepatitis C: Current Disease Management “Strict abstinence from alcohol is recommended during therapy with interferon. Interferon therapy can be associated with relapse in people with a previous history of drug or alcohol abuse. Therefore, alpha interferon should be given with caution to a patient who has only recently stopped alcohol…
